Brookdale Senior Living (BKD) Receives a Buy from Barclays
Barclays analyst Andrew Mok CFA maintained a Buy rating on Brookdale Senior Living today and set a price target of $18.00.
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Mok CFA is an analyst with an average return of -1.5% and a 49.80% success rate. Mok CFA covers the Healthcare sector, focusing on stocks such as Brookdale Senior Living, Humana, and Molina Healthcare.
Brookdale Senior Living has an analyst consensus of Strong Buy, with a price target consensus of $16.88.
Based on Brookdale Senior Living’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $777.84 million and a GAAP net loss of $114.73 million. In comparison, last year the company earned a revenue of $746.41 million and had a GAAP net loss of $50.72 million
Read More on BKD:
Disclaimer & DisclosureReport an Issue
- Brookdale Senior Living Reports Strong 2025 Results, Refinances Debt
- Brookdale Senior Living reports Q4 EPS (17c) vs. (37c) last year
- Brookdale Senior Living still sees 2026 adjusted EBITDA $502M-$516M
- BKD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Brookdale Senior Living price target raised to $18 from $15 at Barclays
